Frankly Speaking: Kat Wade chats about the challenges and opportunities in pharma marketing in 2024

May 20

We had the pleasure of sitting down with Kat Wade, an experienced pharma marketer, to explore the challenges and opportunities in the industry for 2024. Kat brings a wealth of experience having worked both agency-side to provide strategic counsel to clients delivering integrated campaigns, and also client-side as the Head of Retail at Zoetis. 


In our conversation, Kat shared her insights on navigating the evolving landscape of Australian pharma marketing, offering advice on getting bold and innovative work approved and tips for fostering a strong client-agency relationship. She highlights key challenges, including balancing audience content expectations with pharma’s risk-averse nature, and discusses strategies for overcoming these hurdles.

What are some of the biggest challenges and opportunities facing pharma marketers today?

The key challenge I see plenty of is an oldie but a goodie; the ever-growing disconnect between audience content expectations and what’s executable from a pharma risk-appetite perspective. Consumer and HCP audiences alike are conditioned by content trends from a broad range of media channels which often offer succinct, authentic, and entertaining takes on all topics and subjects in life. And why wouldn’t these expectations apply to health information for patients and HCPs? Understandably rigorous medical and legal approval processes can hamper even the most cautious creative attempts at developing audience-centric content and finding the balance between perceived risks and the reward of engaging content can be very difficult to negotiate.

Leaning on a clear process, transparent risk mitigation strategies and a collaborative relationship with approvers, the marketers that can figure out how to navigate this dynamic will be rewarded with more effective comms that move their brand or cause forward. My advice would be to start small; find the right pockets of opportunity within broader campaigns where authenticity can be delivered in a meaningful way for the audience and build broader team confidence through those wins.

For pharma marketers who want to do bold & innovative campaigns, what can they do help get their organisation onboard and content through approvals?

Being ‘bold’ and ‘innovative’ can mean very different things to different organisations. Ensure that you’re tapped into what is relative ‘boldness’ and ‘innovation’ for your context and be aware of the culture that you’re operating in. Uncover the anxieties of your key approval-stakeholders early and provide the right level of context so they understand the ‘why’ and buy into the activity as a sponsor who is also invested in getting the activity over the line. Being ‘bold’ and ‘innovative’ within health takes a village, so foster that culture overtime by prioritising progress over perfection and acknowledge that innovation is a journey, not a destination.  

Having worked both pharma side and agency side, what do you think is important for a healthy and effective agency / client relationship?

The grass is always greener on the other side, right?!

If you’re struggling to understand why your agency/client isn’t doing [insert classic frustration here] as a starting point I’d recommend gaining a true understanding of the context and environment they’re working within. I love having clients in the agency environment to help build their context on how we work and how much human energy across disciplines is committed to their work. Likewise, working pharma client side built an incredible appreciation for the unique pressure marketers are under in those environments; layers upon layers of internal stakeholders, approval processes and a load of competing pressures. Having a little empathy goes a long way; on both sides everyone is typically just trying to do a good job and add value. As an agency, we want our clients to look great by delivering quality work and the more context, transparent communications, and humility we share with clients, the better we can do.

Keen to hear more from Kat? Head over to her LinkedIn to connect.

Articles we think you'd like

Frankly Speaking: Jethro Marsh

Jethro Marsh is an experienced commercial leader, who most recently has been leading the strategy and solutions division at Roche Diagnostics. We sat down to hear his thoughts on industry challenges and commercial effectiveness.

How to maximise your presence at medical meetings with social media

Whether it be an in-person or virtual event, learn how to enhance your company's presence at a meeting with the use of social media.

How to optimise your content to rank in social search

Search on social media is on the rise. Learn how to optimise your healthcare social media content for social search.

Select a course to start your learning journey

Created with